ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01824290
Recruitment Status : Recruiting
First Posted : April 4, 2013
Last Update Posted : May 21, 2018
Sponsor:
Information provided by (Responsible Party):
Eli Lilly and Company

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : January 2021
  Estimated Study Completion Date : January 2023